A Phase 1b/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody®-CD3 X CD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter’s Syndrome

Project: Research

Project Details

StatusActive
Effective start/end date26/07/2326/07/25

Keywords

  • clinical trial
  • Leukemia
  • Richter’s Syndrome
  • Epcoritamab